{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:19:13Z","timestamp":1780669153066,"version":"3.54.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"SI3","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR46849"],"award-info":[{"award-number":["R01 AR46849"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG068192"],"award-info":[{"award-number":["R01 AG068192"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG034676"],"award-info":[{"award-number":["R01 AG034676"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24 AG078179)"],"award-info":[{"award-number":["K24 AG078179)"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["UL1 TR002377"],"award-info":[{"award-number":["UL1 TR002377"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Active RA has been associated with an increased risk of both cardiovascular and peripheral vascular disease. We aimed to compare cerebrovascular changes in patients with and without RA, both with and without a neuropathologic diagnosis of neurodegenerative disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with RA (n\u2009=\u200932) who died and underwent autopsy between 1994 and 2021 were matched to non-RA controls (n\u2009=\u200932) on age, sex and level of neurodegenerative proteinopathy. Routine neuropathologic examination was performed at the time of autopsy. Cerebrovascular disease severity was evaluated using modified Kalaria and Strozyk scales. Clinical dementia diagnoses were manually collected from patients\u2019 medical records.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Prior to death, 15 (47%) RA patients and 14 (44%) controls were diagnosed with dementia; 9 patients in each group (60% and 64%, respectively) had Alzheimer\u2019s disease. The prevalence of cerebral amyloid angiopathy, microinfarcts, infarcts or strokes was found to be similar between groups. Patients with RA were more likely to have more severe vascular changes in the basal ganglia by Kalaria scale (P\u2009=\u20090.04), but not in other brain areas. There were no significant differences in the presence of large infarcts, lacunar infarcts or leukoencephalopathy by Strozyk scale. Among patients with RA and no clinical diagnosis of dementia, the majority had mild\u2013moderate cerebrovascular abnormalities, and a subset of patients had Alzheimer\u2019s disease neuropathologic changes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this small series of autopsies, patients with and without RA had largely similar cerebrovascular pathology when controlling for neurodegenerative proteinopathies, although patients with RA exhibited more pronounced cerebrovascular disease in the basal ganglia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead396","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T23:10:00Z","timestamp":1698102600000},"page":"SI296-SI303","source":"Crossref","is-referenced-by-count":3,"title":["Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"62","author":[{"given":"Rachel A","family":"Larsen","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Neuropathology Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Constantopoulos","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Neuropathology Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanakya","family":"Kodishala","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lovering","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassondra A","family":"Hulshizer","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Lennon","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-7475","authenticated-orcid":false,"given":"Cynthia S","family":"Crowson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"},{"name":"Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aivi T","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Neuropathology Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-1436","authenticated-orcid":false,"given":"Elena","family":"Myasoedova","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Mayo Clinic , Rochester, MN, USA"},{"name":"Department of Quantitative Health Sciences, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"2023102323091916000_kead396-B1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023102323091916000_kead396-B2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B3","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.23650","article-title":"High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study","volume":"58","author":"Kremers","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B4","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","article-title":"Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis","volume":"47","author":"Wiseman","year":"2016","journal-title":"Stroke"},{"key":"2023102323091916000_kead396-B6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.semarthrit.2020.09.022","article-title":"Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis","volume":"51","author":"Sattui","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2023102323091916000_kead396-B7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3899\/jrheum.220200","article-title":"Risk factors for dementia in patients with incident rheumatoid arthritis: a population-based cohort study","volume":"50","author":"Kodishala","year":"2023","journal-title":"J Rheumatol"},{"key":"2023102323091916000_kead396-B8","doi-asserted-by":"crossref","first-page":"e0186475","DOI":"10.1371\/journal.pone.0186475","article-title":"Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: a nationwide cohort study","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"2023102323091916000_kead396-B9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.semarthrit.2021.06.003","article-title":"Trends in incidence of dementia among patients with rheumatoid arthritis: a population-based cohort study","volume":"51","author":"Kronzer","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2023102323091916000_kead396-B10","doi-asserted-by":"crossref","first-page":"e0229819","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor necrosis factor (TNF) blocking agents are associated with lower risk for Alzheimer\u2019s disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PLoS One"},{"key":"2023102323091916000_kead396-B11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for rheumatoid arthritis and risk of Alzheimer\u2019s disease: a nested case-control analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"key":"2023102323091916000_kead396-B12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.trci.2017.10.002","article-title":"Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients","volume":"3","author":"Judge","year":"2017","journal-title":"Alzheimers Dement (NY)"},{"key":"2023102323091916000_kead396-B13","doi-asserted-by":"crossref","first-page":"152083","DOI":"10.1016\/j.semarthrit.2022.152083","article-title":"Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - analysis of a national claims database","volume":"57","author":"Sattui","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2023102323091916000_kead396-B14","doi-asserted-by":"crossref","first-page":"e226567","DOI":"10.1001\/jamanetworkopen.2022.6567","article-title":"Comparative risk of Alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023102323091916000_kead396-B15","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1212\/WNL.0000000000201489","article-title":"Inflammatory diseases, inflammatory biomarkers, and Alzheimer disease: an observational analysis and Mendelian randomization","volume":"100","author":"Huang","year":"2023","journal-title":"Neurology"},{"key":"2023102323091916000_kead396-B16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-220368","article-title":"Rheumatoid arthritis, cognitive impairment, and neuroimaging biomarkers: results from the Mayo Clinic Study of Aging","volume":"89","author":"Vassilaki","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2023102323091916000_kead396-B17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10571-016-0334-7","article-title":"The science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline","volume":"36","author":"Corriveau","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"2023102323091916000_kead396-B18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(02)00090-8","article-title":"Immune reactive cells in senile plaques and cognitive decline in Alzheimer\u2019s disease","volume":"24","author":"Vehmas","year":"2003","journal-title":"Neurobiol Aging"},{"key":"2023102323091916000_kead396-B20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","article-title":"Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease","volume":"179","author":"Serrano-Pozo","year":"2011","journal-title":"Am J Pathol"},{"key":"2023102323091916000_kead396-B21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00401-022-02465-w","article-title":"Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI","volume":"144","author":"Nguyen","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2023102323091916000_kead396-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"2023102323091916000_kead396-B23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bpa.12041","article-title":"Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases","volume":"23","author":"Craggs","year":"2013","journal-title":"Brain Pathol"},{"key":"2023102323091916000_kead396-B24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","article-title":"Staging and natural history of cerebrovascular pathology in dementia","volume":"78","author":"Deramecourt","year":"2012","journal-title":"Neurology"},{"key":"2023102323091916000_kead396-B25","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.neurobiolaging.2008.09.011","article-title":"Contribution of vascular pathology to the clinical expression of dementia","volume":"31","author":"Strozyk","year":"2010","journal-title":"Neurobiol Aging"},{"key":"2023102323091916000_kead396-B26","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","edition":"4th edn"},{"key":"2023102323091916000_kead396-B27","author":"Ellison","year":"2012"},{"key":"2023102323091916000_kead396-B28","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","article-title":"Intracranial atherosclerosis","volume":"383","author":"Qureshi","year":"2014","journal-title":"Lancet"},{"key":"2023102323091916000_kead396-B29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jacc.2019.12.033","article-title":"The Alzheimer\u2019s disease amyloid-beta hypothesis in cardiovascular aging and disease: JACC focus seminar","volume":"75","author":"Stakos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023102323091916000_kead396-B30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00325481.2019.1657776","article-title":"Alzheimer\u2019s dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline","volume":"131","author":"Wanleenuwat","year":"2019","journal-title":"Postgrad Med"},{"key":"2023102323091916000_kead396-B31","doi-asserted-by":"crossref","first-page":"e007495","DOI":"10.1161\/CIRCIMAGING.117.007495","article-title":"Myocardial microvascular dysfunction in rheumatoid arthritis (quantitation by 13N-ammonia positron emission tomography\/computed tomography)","volume":"12","author":"Amigues","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023102323091916000_kead396-B32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.24108","article-title":"Coronary microvascular dysfunction in rheumatoid arthritis compared to diabetes mellitus and association with all-cause mortality","volume":"73","author":"Liao","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023102323091916000_kead396-B33","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/heartjnl-2019-316193","article-title":"Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study","volume":"106","author":"Nikiphorou","year":"2020","journal-title":"Heart"},{"key":"2023102323091916000_kead396-B34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B35","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023102323091916000_kead396-B36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.114.011147","article-title":"Cause and mechanisms of intracranial atherosclerosis","volume":"130","author":"Ritz","year":"2014","journal-title":"Circulation"},{"key":"2023102323091916000_kead396-B37","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/STROKEAHA.111.648667","article-title":"Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population","volume":"43","author":"Bos","year":"2012","journal-title":"Stroke"},{"key":"2023102323091916000_kead396-B38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer\u2019s disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"2023102323091916000_kead396-B39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"2023102323091916000_kead396-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2023102323091916000_kead396-B41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"2023102323091916000_kead396-B42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023102323091916000_kead396-B43","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3899\/jrheum.200842","article-title":"Improved incidence of cardiovascular disease in patients with incident rheumatoid arthritis in the 2000s: a population-based cohort study","volume":"48","author":"Myasoedova","year":"2021","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/SI3\/SI296\/52439870\/kead396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/SI3\/SI296\/52439870\/kead396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T23:10:16Z","timestamp":1698102616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/SI3\/SI296\/7328902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":43,"journal-issue":{"issue":"SI3","published-online":{"date-parts":[[2023,10,23]]},"published-print":{"date-parts":[[2023,10,23]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead396","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,10,1]]}}}